Steve Valiquette
Stock Analyst at Barclays
(2.42)
# 2,371
Out of 4,751 analysts
175
Total ratings
48.25%
Success rate
-2.78%
Average return
Main Sectors:
Stocks Rated by Steve Valiquette
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TDOC Teladoc Health | Maintains: Overweight | $10 → $12 | $9.50 | +26.32% | 13 | Oct 31, 2024 | |
| WBA Walgreens Boots Alliance | Maintains: Underweight | $7 → $8 | $11.23 | -28.76% | 15 | Oct 16, 2024 | |
| MCK McKesson | Maintains: Overweight | $596 → $616 | $620.85 | -0.78% | 6 | Aug 8, 2024 | |
| GDRX GoodRx Holdings | Maintains: Overweight | $8 → $9 | $4.98 | +80.72% | 7 | Mar 1, 2024 | |
| HOUS Anywhere Real Estate | Maintains: Underweight | $4.5 → $5 | $3.61 | +38.50% | 3 | Feb 20, 2024 | |
| MPW Medical Properties Trust | Maintains: Overweight | $12 → $10 | $5.58 | +79.21% | 5 | Aug 22, 2023 | |
| HR Healthcare Realty Trust | Maintains: Equal-Weight | $25 → $24 | $16.81 | +42.77% | 4 | Aug 11, 2023 | |
| CVS CVS Health | Maintains: Overweight | $89 → $86 | $64.48 | +33.37% | 14 | Aug 3, 2023 | |
| CNC Centene | Maintains: Overweight | $86 → $85 | $58.19 | +46.07% | 6 | Jul 31, 2023 | |
| HCA HCA Healthcare | Maintains: Equal-Weight | $275 → $300 | $320.94 | -6.52% | 4 | Jun 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $93 → $88 | $91.68 | -4.01% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $35 → $34 | $34.77 | -2.21% | 3 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $70 → $105 | $130.48 | -19.53% | 3 | Apr 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $57 → $55 | $68.66 | -19.90% | 3 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $13 | $16.45 | -20.97% | 11 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $132 → $142 | $186.06 | -23.68% | 2 | Apr 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $5 | $23.64 | -78.85% | 4 | Apr 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $57 | $100.34 | -43.19% | 2 | Mar 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $78 → $82 | $151.52 | -45.88% | 5 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $20 → $18 | $20.18 | -10.80% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $31 | $36.84 | -15.85% | 2 | Jan 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $400 → $375 | $292.98 | +28.00% | 3 | Jan 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $20 → $19 | $26.02 | -26.98% | 2 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $8 → $7 | $5.89 | +18.95% | 2 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $500 → $570 | $261.44 | +118.02% | 4 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $70 → $64 | $127.47 | -49.79% | 4 | May 26, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $275 → $310 | $302.92 | +2.34% | 16 | May 23, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $495 → $565 | $468.56 | +20.58% | 3 | Mar 30, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $280 → $240 | $23.15 | +936.72% | 2 | Nov 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $150 → $75 | $15.75 | +376.19% | 4 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $26 → $19 | $3.26 | +482.82% | 2 | Aug 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $6 → $10 | $3.34 | +199.40% | 10 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $42 → $34 | $18.04 | +88.47% | 4 | May 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $20 | $4.38 | +356.62% | 1 | May 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $260 | $111.04 | +134.15% | 1 | Feb 19, 2021 |
Teladoc Health
Oct 31, 2024
Maintains: Overweight
Price Target: $10 → $12
Current: $9.50
Upside: +26.32%
Walgreens Boots Alliance
Oct 16, 2024
Maintains: Underweight
Price Target: $7 → $8
Current: $11.23
Upside: -28.76%
McKesson
Aug 8, 2024
Maintains: Overweight
Price Target: $596 → $616
Current: $620.85
Upside: -0.78%
GoodRx Holdings
Mar 1, 2024
Maintains: Overweight
Price Target: $8 → $9
Current: $4.98
Upside: +80.72%
Anywhere Real Estate
Feb 20, 2024
Maintains: Underweight
Price Target: $4.5 → $5
Current: $3.61
Upside: +38.50%
Medical Properties Trust
Aug 22, 2023
Maintains: Overweight
Price Target: $12 → $10
Current: $5.58
Upside: +79.21%
Healthcare Realty Trust
Aug 11, 2023
Maintains: Equal-Weight
Price Target: $25 → $24
Current: $16.81
Upside: +42.77%
CVS Health
Aug 3, 2023
Maintains: Overweight
Price Target: $89 → $86
Current: $64.48
Upside: +33.37%
Centene
Jul 31, 2023
Maintains: Overweight
Price Target: $86 → $85
Current: $58.19
Upside: +46.07%
HCA Healthcare
Jun 28, 2023
Maintains: Equal-Weight
Price Target: $275 → $300
Current: $320.94
Upside: -6.52%
May 5, 2023
Maintains: Equal-Weight
Price Target: $93 → $88
Current: $91.68
Upside: -4.01%
May 3, 2023
Maintains: Underweight
Price Target: $35 → $34
Current: $34.77
Upside: -2.21%
Apr 26, 2023
Maintains: Overweight
Price Target: $70 → $105
Current: $130.48
Upside: -19.53%
Apr 25, 2023
Maintains: Overweight
Price Target: $57 → $55
Current: $68.66
Upside: -19.90%
Apr 25, 2023
Maintains: Equal-Weight
Price Target: $15 → $13
Current: $16.45
Upside: -20.97%
Apr 25, 2023
Upgrades: Equal-Weight
Price Target: $132 → $142
Current: $186.06
Upside: -23.68%
Apr 5, 2023
Maintains: Underweight
Price Target: $13 → $5
Current: $23.64
Upside: -78.85%
Mar 14, 2023
Initiates: Equal-Weight
Price Target: $57
Current: $100.34
Upside: -43.19%
Jan 17, 2023
Maintains: Overweight
Price Target: $78 → $82
Current: $151.52
Upside: -45.88%
Jan 17, 2023
Maintains: Overweight
Price Target: $20 → $18
Current: $20.18
Upside: -10.80%
Jan 17, 2023
Maintains: Equal-Weight
Price Target: $33 → $31
Current: $36.84
Upside: -15.85%
Jan 4, 2023
Maintains: Overweight
Price Target: $400 → $375
Current: $292.98
Upside: +28.00%
Oct 21, 2022
Maintains: Equal-Weight
Price Target: $20 → $19
Current: $26.02
Upside: -26.98%
Oct 21, 2022
Maintains: Overweight
Price Target: $8 → $7
Current: $5.89
Upside: +18.95%
Jul 28, 2022
Maintains: Overweight
Price Target: $500 → $570
Current: $261.44
Upside: +118.02%
May 26, 2022
Downgrades: Equal-Weight
Price Target: $70 → $64
Current: $127.47
Upside: -49.79%
May 23, 2022
Maintains: Overweight
Price Target: $275 → $310
Current: $302.92
Upside: +2.34%
Mar 30, 2022
Maintains: Overweight
Price Target: $495 → $565
Current: $468.56
Upside: +20.58%
Nov 11, 2021
Maintains: Equal-Weight
Price Target: $280 → $240
Current: $23.15
Upside: +936.72%
Nov 10, 2021
Downgrades: Equal-Weight
Price Target: $150 → $75
Current: $15.75
Upside: +376.19%
Aug 12, 2021
Upgrades: Overweight
Price Target: $26 → $19
Current: $3.26
Upside: +482.82%
Aug 3, 2021
Maintains: Underweight
Price Target: $6 → $10
Current: $3.34
Upside: +199.40%
May 28, 2021
Downgrades: Underweight
Price Target: $42 → $34
Current: $18.04
Upside: +88.47%
May 24, 2021
Initiates: Overweight
Price Target: $20
Current: $4.38
Upside: +356.62%
Feb 19, 2021
Reinstates: Overweight
Price Target: $260
Current: $111.04
Upside: +134.15%